Not a good protocol, no Hydroxychloroquine mentioned.
Hydroxycloroquine is Back
- Thread starter apdxyk
- Start date
Sorry you have dry humor...usually I'm not able to recognize tongue in cheek commentary.
Regardless, its not your posts but its really about the readers I'm talking to that are reading your message posts and may not recognize your tongue in cheek commentary. They need to be inform to ensure they do not take your commentary as fact.
As for my own posts...there length stay the same whenever I'm using facts and you're welcome to not read the facts whenever you become tired especially on a trading day. Wouldn't want to see you have problems after the 2nd sentence.
While you're at it...you may want to keep your replies shorter too especially when you bundle them with your version of the facts. There's just too much info to fact check. Don't take it personally, some of the facts are very accurate while others are...lets say misinformation but I've notice less of the latter lately.
I appreciate the less misinformation...bravo
Hint: My posts are long when I post facts because a few idiots stated when I post links to the health info...they don't bother to read the info at the links. I then give a shorter version (summary) instead of posting all the links.
wrbtrader
Last edited:
In addition, the average person doesn't have access to that type of therapeutic treatment regime. Worst, many hospitals don't use it for whatever reason.
That's not unusual...its typical for new diseases. Usually it takes 1 - 2 years for everybody to get on the same page assuming there's a national plan for the healthcare system.
Thus, all the debates tend to occur within the first year of a new disease. It's been that way since the early 1900's.
wrbtrader
"4542 received HCQ in monotherapy and 3533 were in the no-HCQ group. Death was reported in 804/4542 (17.7%) and 957/3533 (27.1%), respectively."
https://www.sciencedirect.com/science/article/pii/S0924857920303423#
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
https://www.sciencedirect.com/science/article/pii/S0924857920303423#
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
In the Netherlands a scientific research came to the following results:
Results:
Among 1893 included subjects, 21-day mortality was 23.4% in 1552 subjects treated in hospitals that routinely prescribed (hydroxy)chloroquine, and 17.0% in 341 subjects that were treated in hospitals that did not. In the adjusted Cox-regression models this difference disappeared, with an adjusted hazard ratio of 1.17 (95%CI 0.88-1.55). When stratified by actually received treatment in individual subjects, the use of (hydroxy)chloroquine was associated with an increased 21-day mortality (HR 1.58; 95%CI 1.25-2.01) in the full model.
Conclusions:
After adjustment for confounders, mortality was not significantly different in hospitals that routinely treated patients with (hydroxy)chloroquine, compared with hospitals that did not. We compared outcomes of hospital strategies rather than outcomes of individual patients to reduce the chance of indication bias. This study adds evidence against the use of (hydroxy)chloroquine in patients with
COVID-19.
You can read the full article in the added pdf.
This is what Belgium concluded after tests:
In Belgium, at least 5,000 of the 17,628 hospitalized corona patients have received hydroxychloroquine. The drug is controversial, as there is no evidence yet that it works against Covid-19. Belgium has the highest death rate in the world.
Maybe thanks to the use of hydroxychloroquine?
Results:
Among 1893 included subjects, 21-day mortality was 23.4% in 1552 subjects treated in hospitals that routinely prescribed (hydroxy)chloroquine, and 17.0% in 341 subjects that were treated in hospitals that did not. In the adjusted Cox-regression models this difference disappeared, with an adjusted hazard ratio of 1.17 (95%CI 0.88-1.55). When stratified by actually received treatment in individual subjects, the use of (hydroxy)chloroquine was associated with an increased 21-day mortality (HR 1.58; 95%CI 1.25-2.01) in the full model.
Conclusions:
After adjustment for confounders, mortality was not significantly different in hospitals that routinely treated patients with (hydroxy)chloroquine, compared with hospitals that did not. We compared outcomes of hospital strategies rather than outcomes of individual patients to reduce the chance of indication bias. This study adds evidence against the use of (hydroxy)chloroquine in patients with
COVID-19.
You can read the full article in the added pdf.
This is what Belgium concluded after tests:
In Belgium, at least 5,000 of the 17,628 hospitalized corona patients have received hydroxychloroquine. The drug is controversial, as there is no evidence yet that it works against Covid-19. Belgium has the highest death rate in the world.
Maybe thanks to the use of hydroxychloroquine?
Last edited:
A full vaccine roll out may take years. Large part of the population is not going to get it. Effect may be short term.
So no, HCQ and other treatments are here to stay.
It's already old news...other drugs are being approved (e.g. remdesivir treatment) or other therapeutics here in Canada. Most likely soon to be approved in the USA.
In fact, I believe remdesivir treatment will be approved in the USA before HCQ because remdesivir treatment is already being used in Canada and other countries...successfully.
Yeah, I agree that a vaccine roll out won't be approved any time soon unless the White House puts pressure on the FDA to take short cuts in the safety to get it to market before the November election...staying in line with a promise by the U.S. President.
Thus, of course HCQ is here to stay just like the other drug treatments that have not been approved for Covid-19 while approved for other treatments...HCQ is approved for treatment for malaria. HCQ isn't going anywhere...literally.
wrbtrader
